For critically ill patients requiring dialysis, insertion of the catheter in a vein in the neck does not appear to reduce the risk of infection compared to vein access in the upper leg, except for ...
Central venous catheters are frequently used in leukapheresis to provide high flow rates. The most common locations are the subclavian or jugular vein, but insertion-related complications and ...
Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...
The effectiveness of various solutions instilled into the central venous catheter lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of catheter malfunction and ...
Please provide your email address to receive an email when new articles are posted on . Two randomized trials reported discordant intervention effects. Results highlight a need for further study to ...
The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results